Anbio Biotechnology Limited

NNNN · Germany

anbiobiotechnology.com

Financials as of FY2025

What stands out
  • Earnings significantly exceed cash generation
At a glance
  • Depends onUpstream position: supplies 5 industries, depends on 1
  • ScaleMarket cap is $158.01M, lower than 95% of all stocks globally
  • PositionOperating margin is 66.7%, higher than 95% of its Medical Instruments & Supplies peers (median 12.4%)
  • Interpretations11 currently firing — 11